Safety and Efficacy of a Combination of 5-Azacitidine Followed by Lenalidomide in High-Risk MDS or AML Patients with Del(5q) Cytogenetic Abnormalities - Results of the "AZALE" Trial
2011 | conference abstract. A publication with affiliation to the University of Göttingen.
Jump to: Cite & Linked | Documents & Media | Details | Version history
Cite this publication
Safety and Efficacy of a Combination of 5-Azacitidine Followed by Lenalidomide in High-Risk MDS or AML Patients with Del(5q) Cytogenetic Abnormalities - Results of the "AZALE" Trial
Platzbecker, U.; Ganster, C.; Neesen, J.; Kuendgen, A.; Goetze, K. S.; Bug, G. & Shirneshan, K. et al. (2011)
Blood, 118(21) 53rd Annual Meeting and Exposition of the American-Society-of-Hematology (ASH)/Symposium on the Basic Science of Hemostasis and Thrombosis, San Diego, CA.
Washington: Amer Soc Hematology.
Documents & Media
Details
- Authors
- Platzbecker, Uwe; Ganster, Christina; Neesen, Juergen; Kuendgen, Andrea; Goetze, Katharina S.; Bug, Gesine; Shirneshan, Katayoon; Braulke, Friederike; Roellig, Christoph; Naumann, Ralph; Buessemaker, Eckhard; Giagounidis, Aristoteles A. N.; Hofmann, Wolf-Karsten; Germing, Ulrich; Haase, Detlef; Ehninger, Gerhard
- Issue Date
- 2011
- Status
- published
- Publisher
- Amer Soc Hematology
- Journal
- Blood
- Conference
- 53rd Annual Meeting and Exposition of the American-Society-of-Hematology (ASH)/Symposium on the Basic Science of Hemostasis and Thrombosis
- Conference Place
- San Diego, CA
- ISSN
- 0006-4971
- Extent
- 1623
